US$ 26.44
igf-1 lr3 clinical trial humans human protein 1000 µg Human E. coli RUO Recombinant Human IGF-1 LR3
Description
It's absolutely mind blowing to me
doi: 10.1016/j.molmed.2014.03.002


By converting APAP into water-soluble forms, this phase II pathway helps detoxify and eliminate APAP from the body, reducing the risk of metabolite accumulation and potential harm

Kim W, Lee S, Seo D, Kim D, Kim K, Kim E, et al

Analysis of in Vitro Aptamer Selection Parameters
